China Biotech Services Holdings Limited announced that with effect from 30 June 2023, Ms. Chui Hoi Yam has been re-designated from an executive Director to a non-executive Director. Ms. Chui will continue to devote her time to the Company and contribute her valuable skills and experience to the overall strategic development and long-term growth of the Group in her role as a non-executive Director. Ms. Chui, aged 56, was appointed as an executive Director on 5 December 2022 and re-designated as a non-executive Director with effect from 30 June 2023.

Prior to joining the Group, Ms. Chui was a president of Harbin Pharmaceutical Group Co. Ltd., from March 2019 to May 2022 and was a director of Harbin Pharmaceutical from January 2021 to May 2022, where she was responsible for the overall business operation. Ms. Chui previously worked in China Hewlett-Packard Co.

Ltd. and Novartis International. Ms. Chui received her bachelor's degree in economic administration and master's degree in finance from Peking University, the People's Republic of China in July 1990 and July 2001, respectively.